Cipla Ltd has acquired Indian regulatory approval to sell anti-viral drug favipiravir to treat the virus COVID-19, the Cipla told on Friday, as coronavirus infections
Cipla Ltd has acquired Indian regulatory approval to sell anti-viral drug favipiravir to treat the virus COVID-19, the Cipla told on Friday, as coronavirus infections